Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 2/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
| ▸ | PNP | P00491 | 3/20 | 0.44 |
| ▸ | BLM | P54132 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | EDNRA | P25101 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | HBB | P68871 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | VCP | P55072 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28260991 | 0.90 | TK1 (0.44) | TK1ADORA3PNPBLMUSP2 | |
| SCHEMBL237755 | 0.87 | HPGD (0.46) | TK1ADORA3PNPBLMUSP2 | |
| SCHEMBL28747968 | 0.86 | TK1 (0.44) | TK1ADORA3PNPBLMUSP2 | |
| SCHEMBL1506536 | 0.85 | POLB (0.51) | PNPHPRT1 | |
| SCHEMBL28252469 | 0.85 | TK1 (0.41) | TK1ADORA3PNPBLMUSP2 | |
| SCHEMBL16555280 | 0.84 | TK1 (0.44) | TK1ADORA3PNPBLMUSP2 | |
| SCHEMBL30399088 | 0.84 | TK1 (0.45) | TK1ADORA3PNPBLMUSP2 | |
| SCHEMBL28707584 | 0.84 | TK1 (0.46) | TK1ADORA3PNPBLMUSP2 | |
| Guanosine SCHEMBL27082152 | 0.84 | ADORA3 (0.58) | ADORA3HPGDMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL442605 | 0.83 | ADORA3 (0.48) | TK1ADORA3PNPBLMUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 312 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| CN-114373510-B | Metabolic marker for diagnosing or monitoring lung cancer and screening method and application thereof | 武汉迈特维尔医学科技有限公司 | 2023-12-01 | — | — | CN | claimed |
| WO-2023083197-A1 | METABOLIC MARKER FOR DIAGNOSING OR MONITORING LUNG CANCER, AND SCREENING METHOD THEREFOR AND USE THEREOF | 武汉迈特维尔医学科技有限公司 | 2023-05-19 | — | — | WO | claimed |
| CN-109425670-B | Method for detecting fatigue degree of team based on human urine | 中国民用航空局民用航空医学中心 | 2022-09-16 | — | — | CN | claimed |
| CN-109425669-B | Method for screening biomarkers related to fatigue degree in human body fluid by liquid chromatography-mass spectrometry | 中国民用航空局民用航空医学中心 | 2022-09-16 | — | — | CN | claimed |
| CN-114373510-A | Metabolic marker for lung cancer diagnosis or monitoring and screening method and application thereof | 武汉迈特维尔生物科技有限公司 | 2022-04-19 | — | — | CN | claimed |
| WO-2022075354-A1 | A METHOD FOR OBTAINING AN INDEX FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE (AD) | OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) | 2022-04-14 | — | — | WO | claimed |
| CN-107607641-B | Method for detecting mild and moderate fatigue degrees of civil aviation air traffic controller team | 中国民用航空总局第二研究所 | 2020-09-08 | — | — | CN | claimed |
| EP-3529255-A1 | TRINUCLEOTIDE MRNA CAP ANALOGS | Arcturus Therapeutics, Inc. (US) | 2019-08-28 | — | — | EP | claimed |
| US-20190101525-A1 | METHOD FOR DETERMINING THE EXTENT OF AGING OF A SUBJECT AND TREATING THE SUBJECT TO SUPPRESS THE EXTENT OF AGING | OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) | 2019-04-04 | — | — | US | claimed |
| CN-109425670-A | A method of teams and groups' degree of fatigue is detected based on human urine | 中国民用航空局民用航空医学中心 | 2019-03-05 | — | — | CN | claimed |
| CN-108780099-A | A kind of method, apparatus, system and kit for measuring degree of aging | 学校法人冲绳科学技术大学院大学学园 | 2018-11-09 | — | — | CN | claimed |
| CN-108693268-A | A kind of combination of metabolic marker object and its kit for predicting coronary heart disease prognosis | 百迈康生物医药科技(广州)有限公司 | 2018-10-23 | — | — | CN | claimed |
| WO-2018075827-A1 | TRINUCLEOTIDE MRNA CAP ANALOGS | ARCTURUS THERAPEUTICS, INC. (US) | 2018-04-26 | — | — | WO | claimed |
| CN-107607641-A | Air traffic control person teams and groups are slight and the detection method of moderate degree of fatigue | 中国民用航空总局第二研究所 | 2018-01-19 | — | — | CN | claimed |
| WO-2013177222-A1 | METABOLITE BIOMARKERS FOR THE DETECTION OF LIVER CANCER | PURDUE RESEARCH FOUNDATION (US) | 2013-11-28 | — | — | WO | claimed |
| WO-2001085220-A1 | LABELED NUCLEOSIDES AND METHOD FOR THEIR PREPARATION | RNA-TEC N.V. (BE) | 2001-11-15 | — | — | WO | claimed |
| WO-2026107144-A1 | RNA SEQUENCE FOR EXPRESSING PROTEIN IN CARDIOMYOCYTES | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2026-05-21 | — | — | WO | disclosed |
| EP-0238672-A1 | PROCESS FOR DEOXIDIZING ALCOHOL | Yamasa Shoyu Kabushiki Kaisha (JP) | 1987-09-30 | — | — | EP | disclosed |
| EP-0106894-B1 | METHODS AND TEST KIT FOR DIAGNOSING CANCER IN HUMANS | SRI INTERNATIONAL (US) | 1986-10-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | GLS, AADAT, FGF23 | TK1 1369/4885ADORA3 499/4885PNP 241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.